HIV among injecting drug users: Current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities

Don Des Jarlais, Kamyar Arasteh, Salaam Semaan, Evan Wood

Research output: Contribution to journalReview article

Abstract

Purpose of review: To describe recent research done primarily during the past 12 months (i.e., primarily in 2008) on the epidemiology of HIV infection among injecting drug users (IDUs). Recent findings: Major research developments include a global assessment of HIV infection among IDUs and evidence of a transition from epidemics concentrated among IDUs to generalized, heterosexual epidemics in eastern Europe and Asia. Intervention research also includes several studies of supervised-injecting facilities. Methodological research includes respondent-driven sampling and the use of hepatitis C virus and herpes simplex virus-2 as biomarkers for injecting and sexual risk. Summary: There have been important advances in research during the past year, but HIV infection continues to spread rapidly across many areas of the world among IDUs and their nondrug-using sex partners.

Original languageEnglish (US)
Pages (from-to)308-313
Number of pages6
JournalCurrent Opinion in HIV and AIDS
Volume4
Issue number4
DOIs
StatePublished - Jul 1 2009

Fingerprint

Drug Users
Epidemiology
Biomarkers
HIV
Injections
HIV Infections
Research
Needle-Exchange Programs
Eastern Europe
Human Herpesvirus 2
Far East
Heterosexuality
Hepacivirus
Surveys and Questionnaires

Keywords

  • AIDS
  • Epidemiology
  • HIV
  • Injecting drug use
  • Respondent-driven sampling
  • Supervised-injecting facilities

ASJC Scopus subject areas

  • Immunology
  • Hematology
  • Oncology
  • Oncology(nursing)
  • Infectious Diseases
  • Virology

Cite this

HIV among injecting drug users : Current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities. / Des Jarlais, Don; Arasteh, Kamyar; Semaan, Salaam; Wood, Evan.

In: Current Opinion in HIV and AIDS, Vol. 4, No. 4, 01.07.2009, p. 308-313.

Research output: Contribution to journalReview article

@article{081c28bc193e442996da7b9f217eaee4,
title = "HIV among injecting drug users: Current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities",
abstract = "Purpose of review: To describe recent research done primarily during the past 12 months (i.e., primarily in 2008) on the epidemiology of HIV infection among injecting drug users (IDUs). Recent findings: Major research developments include a global assessment of HIV infection among IDUs and evidence of a transition from epidemics concentrated among IDUs to generalized, heterosexual epidemics in eastern Europe and Asia. Intervention research also includes several studies of supervised-injecting facilities. Methodological research includes respondent-driven sampling and the use of hepatitis C virus and herpes simplex virus-2 as biomarkers for injecting and sexual risk. Summary: There have been important advances in research during the past year, but HIV infection continues to spread rapidly across many areas of the world among IDUs and their nondrug-using sex partners.",
keywords = "AIDS, Epidemiology, HIV, Injecting drug use, Respondent-driven sampling, Supervised-injecting facilities",
author = "{Des Jarlais}, Don and Kamyar Arasteh and Salaam Semaan and Evan Wood",
year = "2009",
month = "7",
day = "1",
doi = "10.1097/COH.0b013e32832bbc6f",
language = "English (US)",
volume = "4",
pages = "308--313",
journal = "Current Opinion in HIV and AIDS",
issn = "1746-630X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - HIV among injecting drug users

T2 - Current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities

AU - Des Jarlais, Don

AU - Arasteh, Kamyar

AU - Semaan, Salaam

AU - Wood, Evan

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Purpose of review: To describe recent research done primarily during the past 12 months (i.e., primarily in 2008) on the epidemiology of HIV infection among injecting drug users (IDUs). Recent findings: Major research developments include a global assessment of HIV infection among IDUs and evidence of a transition from epidemics concentrated among IDUs to generalized, heterosexual epidemics in eastern Europe and Asia. Intervention research also includes several studies of supervised-injecting facilities. Methodological research includes respondent-driven sampling and the use of hepatitis C virus and herpes simplex virus-2 as biomarkers for injecting and sexual risk. Summary: There have been important advances in research during the past year, but HIV infection continues to spread rapidly across many areas of the world among IDUs and their nondrug-using sex partners.

AB - Purpose of review: To describe recent research done primarily during the past 12 months (i.e., primarily in 2008) on the epidemiology of HIV infection among injecting drug users (IDUs). Recent findings: Major research developments include a global assessment of HIV infection among IDUs and evidence of a transition from epidemics concentrated among IDUs to generalized, heterosexual epidemics in eastern Europe and Asia. Intervention research also includes several studies of supervised-injecting facilities. Methodological research includes respondent-driven sampling and the use of hepatitis C virus and herpes simplex virus-2 as biomarkers for injecting and sexual risk. Summary: There have been important advances in research during the past year, but HIV infection continues to spread rapidly across many areas of the world among IDUs and their nondrug-using sex partners.

KW - AIDS

KW - Epidemiology

KW - HIV

KW - Injecting drug use

KW - Respondent-driven sampling

KW - Supervised-injecting facilities

UR - http://www.scopus.com/inward/record.url?scp=67651155916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651155916&partnerID=8YFLogxK

U2 - 10.1097/COH.0b013e32832bbc6f

DO - 10.1097/COH.0b013e32832bbc6f

M3 - Review article

VL - 4

SP - 308

EP - 313

JO - Current Opinion in HIV and AIDS

JF - Current Opinion in HIV and AIDS

SN - 1746-630X

IS - 4

ER -